DoubleLine’s Jeffrey Gundlach sees no more Fed rate cuts under Jerome Powell
DoubleLine Capital CEO Jeffrey Gundlach said Wednesday he expects the Federal Reserve to stay on hold for the…
Health insurers tumble after Trump proposes keeping Medicare rates flat
Stock Chart IconStock chart icon Humana shares in the past day The proposal entails a net average payment…
Meta poised for nearly 40% upside on compelling AI and ad opportunities, analyst says
Meta ‘s advertising engine and expanding AI capabilities position it to unlock meaningful incremental revenue over time, according…
Stock market today: Live updates
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., Jan.…
Financial risks of supporting adult children, according to experts
By some measures, Generation Z is the hardest hit by the affordability crisis. Even though young adults are…
Raymond James upgrades this ‘Magnificent Seven’ titan as AI-driven growth accelerates
Raymond James believes that Alphabet’s artificial intelligence investments support further upside from here. The firm upgraded the “Magnificent…
Nvidia CEO Jensen Huang says AI won’t be the job killer everyone fears. Here’s why
Nvidia CEO Jensen Huang said Wednesday that artificial intelligence will lead to more jobs, not fewer. In an…
Berkshire set to exit 28% stake in Kraft Heinz after rare Buffett blunder
Warren Buffett, Greg Abel and Ajit Jain during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on…
Another alliance of health care and AI signals why pharma stocks could be back
Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the…
Deutsche Bank says the ‘honeymoon is over’ for AI
This year will be the most difficult one yet for artificial intelligence, according to Deutsche Bank Research Institute.…
Software stocks face ‘Innovator’s Dilemma’ as they plunge on AI fears
Software stocks are falling out of favor after years of market leadership, as investors fear the group may…
I talked to many health CEOs out West and see big things for drug stocks
We get so caught up in the buzz and the sizzle that we forget about the steak, especially…